Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload

Purpose Sodium-glucose cotransporter 2 (SGLT2) inhibitors prevent heart failure and decrease cardiovascular mortality in patients with type 2 diabetes. Heart failure is associated with detrimental changes in energy metabolism, and the preservation of cardiac mitochondrial function is crucial for the...

Full description

Bibliographic Details

Published in:	Cardiovascular drugs and therapy Vol. 34; no. 6; pp. 791 - 797
Main Authors:	Makrecka-Kuka, Marina, Korzh, Stanislava, Videja, Melita, Vilks, Karlis, Cirule, Helena, Kuka, Janis, Dambrova, Maija, Liepinsh, Edgars
Format:	Journal Article
Language:	English
Published:	New York Springer US 01.12.2020
Subjects:	Cardiology Medicine Medicine & Public Health Short Communication Fatty acid oxidation Heart Empagliflozin Mitochondria
ISSN:	0920-3206, 1573-7241, 1573-7241
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!